Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 12:03 AM
NCT ID:
NCT03893058
Eligibility Criteria:
Inclusion Criteria:
Adult patients (18-year-old and older ones) hospitalised in ICU. In order to realise the first aim of the study (to estimate the prevalence of NMJ disorders acquired during critical illnesses using SF-EMG), patients with a pathologic PENT will be evaluated. In order to realise the second aim of the study (to assess the reliability of TOF in critically ill patients. The study will evaluate patients with critical illnesses hospitalised in the General Intensive Care Unit), patients who receive NMBAs will be evaluated; patients who do not receive NMBAs will also be evaluated, as a control group.
Exclusion Criteria:
* patients with a terminal disease;
* patients with an ICU-length-of-staying perspective less than 72 hours;
* patients with a chronic disease associated with known neuropathy or myopathy;
* patients treated with drugs that may cause neurotoxicity and myotoxicity;
* patients with primary or secondary acute Peripheral Nervous System (PNS) lesions or muscle lesions;
* patients with prosthesis, wounds or other conditions that prevent electrophysiological testing.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03893058
Study Brief:
Protocol Section:
NCT03893058